We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Hemostasis and Periventricular-Intraventricular Hemorrhage of the Newborn

Margot Van De Bor, MD; Ernest Briet, MD; Frank Van Bel, MD; Jan H. Ruys, MD
Am J Dis Child. 1986;140(11):1131-1134. doi:10.1001/archpedi.1986.02140250057036.
Text Size: A A A
Published online


• In a prospective study we analyzed the role of coagulopathy in the development of periventricular-intraventricular hemorrhage (PIVH) in 49 consecutively admitted preterm infants of less than 34 weeks' gestation by serial ultrasound examinations and coagulation assays. In 20 patients (41%) PIVH was detected. On the day of birth, patients with PIVH had significantly lower levels of factor V than did the patients without PIVH, but all other clotting factors gave similar results, and on the third and fifth days all results were similar, including those for factor V. Even the small subgroup of infants who subsequently developed grade IV hemorrhage did not have a more severe coagulopathy than the other infants, although they had significantly lower levels of platelets and of factor VII at birth. We conclude that coagulopathy does not play an important role in the etiology of PIVH. Standard doses of 10 mL/kg of fresh-frozen plasma, administered to increase the low levels of clotting factors, did not prevent extension of the hemorrhage.

(AJDC 1986;140:1131-1134)


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.